SCHEMBL7229694

SCHEMBL7229694

CCOC(=O)c1sc(NC(=O)O)nc1C(F)(F)F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
HPGD P15428 5/20 0.55
NPC1 O15118 5/20 0.50
P2RY1 P47900 1/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
DHODH Q02127 3/20 0.48
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 6/20 0.47
RAB9A P51151 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KDM4E B2RXH2 4/20 0.47
LMNA P02545 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28342547 0.88 ALDH1A1 (0.56) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL12273225 0.86 TSHR (0.49) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL9750606 0.85 P2RY1 (0.51) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL6195865 0.84 ALDH1A1 (0.47) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL23742065 0.84 HPGD (0.48) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL9750695 0.84 P2RY1 (0.48) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL8507216 0.81 ALDH1A1 (0.51) ALDH1A1HPGDP2RY1MEN1KMT2A
SCHEMBL2145779 0.81 ALDH1A1 (0.54) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL20803509 0.80 CSNK1D (0.48) ALDH1A1HPGDNPC1P2RY1MEN1
SCHEMBL2901073 0.80 MEN1 (0.51) ALDH1A1HPGDNPC1P2RY1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1257886-C Dehydroamino acids compounds HOFFMANN LA ROCHE (CH) 2006-05-31 CN disclosed
CN-1398252-A dehydroamino acid compounds HOFFMANN LA ROCHE (CH) 2003-02-19 CN disclosed
US-6515124-B2 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis HOFFMAN-LA ROCHE INC. 2003-02-04 US disclosed
EP-1261579-A1 DEHYDROAMINO ACIDS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-04 EP disclosed
US-20020161237-A1 Dehydroamino acids HOFFMANN-LA ROCHE INC. 2002-10-31 US disclosed
WO-2001058853-A1 DEHYDROAMINO ACIDS F. HOFFMANN-LA ROCHE AG (CH) 2001-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161237-A1 Dehydroamino acids HSD3B1, CYP8B1, TH ALDH1A1 1300/4885HPGD 153/4885NPC1 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.